S&P Pharmaceutical Company Limited - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for S&P Pharmaceutical Company Limited. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

S&P Pharmaceutical Company Limited Formerly known as S&P Pharmaceutical Industry Company Limited. The Group's principal activities are the research, development, manufacture and sale of Chinese, OTC drugs and Tibetan medicines and health products. Other activities include the wholesale and retail of Chinese and biological products. These products are for cardiovascular and respiratory systems in the form of solutions and capsules. Products include Chongcaojing (an essence made from Chinese caterpillar fungus), Chongcao Shensi oral liquid, Yiganjian (hepatitis medicine) and Xinnaoxin (Tibetan medicine for diseases caused by shortage of oxygen), among others. Operations of the Group are carried out in the People's Republic of China.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report